Francesca Nolan | IR Director |
Doug Ingram | President and CEO |
Louise Rodino-Klapac | EEVP, Chief Scientific Officer and Head of Research & Development |
Dallan Murray | EVP & Chief Customer Officer |
Ian Estepan | EVP & CFO |
Colin Bristow | UBS |
Brian Abrahams | RBC Capital Markets |
Tazeen Ahmad | Bank of America |
Gena Wang | Barclays |
Salveen Richter | Goldman Sachs |
Gil Blum | Needham & Company |
Uy Ear | Mizuho Securities |
Michael Ulz | Morgan Stanley |
Danielle Bongero | Raymond James |
Ritu Baral | TD Cowen |
Anupam Rama | JPMorgan |
Kristen Kluska | Cantor Fitzgerald |
John Boyle | William Blair |
Debjit Chattopadhyay | Guggenheim Securities |
Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded.
At this time.